Your browser doesn't support javascript.
loading
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.
Kohlmeyer, Jordan L; Lingo, Joshua J; Kaemmer, Courtney A; Scherer, Amanda; Warrier, Akshaya; Voigt, Ellen; Raygoza Garay, Juan A; McGivney, Gavin R; Brockman, Qierra R; Tang, Amy; Calizo, Ana; Pollard, Kai; Zhang, Xiaochun; Hirbe, Angela C; Pratilas, Christine A; Leidinger, Mariah; Breheny, Patrick; Chimenti, Michael S; Sieren, Jessica C; Monga, Varun; Tanas, Munir R; Meyerholz, David K; Darbro, Benjamin W; Dodd, Rebecca D; Quelle, Dawn E.
Afiliação
  • Kohlmeyer JL; Molecular Medicine Graduate Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Lingo JJ; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Kaemmer CA; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.
  • Scherer A; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.
  • Warrier A; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Voigt E; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Raygoza Garay JA; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.
  • McGivney GR; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Brockman QR; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.
  • Tang A; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.
  • Calizo A; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Pollard K; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.
  • Zhang X; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.
  • Hirbe AC; Molecular Medicine Graduate Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Pratilas CA; Department of Microbiology and Molecular Cell Biology, Leroy T. Canoles Jr. Cancer Center, Eastern Virginia Medical School, Norfolk, Virginia.
  • Leidinger M; Department of Oncology, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Breheny P; Department of Oncology, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Chimenti MS; Division of Medical Oncology, Washington University, St. Louis, Missouri.
  • Sieren JC; Division of Medical Oncology, Washington University, St. Louis, Missouri.
  • Monga V; Department of Oncology, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Tanas MR; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Meyerholz DK; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.
  • Darbro BW; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa.
  • Dodd RD; Iowa Institute of Human Genetics, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Quelle DE; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.
Clin Cancer Res ; 29(17): 3484-3497, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37410426

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurofibrossarcoma Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurofibrossarcoma Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article